C.E. RICK STRATTAN

Corporate Board Profile

Tech Score: 22/100

← Back to All Directors

Software Technology Evidence

2 mention(s) identify C.E. RICK STRATTAN as having software/technology expertise.

Company Filing Date Evidence Reason
Cyclo Therapeutics, Inc. 2002-03-08 Mr. Strattan is a graduate of the University of Florida receiving a B.S. degree in chemistry and mathematics, and has also received an MS degree in Pharmacology, and an MBA degree in Marketing/Computer Information Sciences, from the same institution. Mr. Strattan has written and published numerous articles and a book chapter on the subject of Cyclodextrins. Mr. Strattan has an MBA degree in Marketing/Computer Information Sciences and has written and published numerous articles and a book chapter on the subject of Cyclodextrins, indicating technical and computer-related knowledge.
Cyclo Therapeutics, Inc. 2004-11-04 Mr. Strattan is a graduate of the University of Florida receiving a B.S. degree in chemistry and mathematics, and has also received an MS degree in Pharmacology, and an MBA degree in Marketing/Computer Information Sciences, from the same institution. Mr. Strattan has written and published numerous articles and a book chapter on the subject of Cyclodextrins. Mr. Strattan has an MBA degree in Marketing/Computer Information Sciences and has written and published numerous articles and a book chapter on the subject of Cyclodextrins, indicating technical expertise including computer information sciences.

Cyclo Therapeutics, Inc.

Filing Date Source Excerpt
2002-03-08 Mr. Strattan is a graduate of the University of Florida receiving a B.S. degree in chemistry and mathematics, and has also received an MS degree in Pharmacology, and an MBA degree in Marketing/Computer Information Sciences, from the same institution. Mr. Strattan has written and published numerous articles and a book chapter on the subject of Cyclodextrins.
2004-11-04 Mr. Strattan is a graduate of the University of Florida receiving a B.S. degree in chemistry and mathematics, and has also received an MS degree in Pharmacology, and an MBA degree in Marketing/Computer Information Sciences, from the same institution. Mr. Strattan has written and published numerous articles and a book chapter on the subject of Cyclodextrins.
2018-04-16 In 2004, the Company created a series of Series A Preferred Stock consisting of a single share that was issued to C.E Rick Strattan, who was the Company’s Chairman and Chief Executive Officer at such time.
2019-07-19 Officers and Directors table listing C.E. Rick Strattan as a director with no mention of technical skills.
2020-09-15 Article 4. Names and Addresses of the Board of Directors (continued) - C.E. RICK STRATTAN
2021-04-29 Mr. Strattan is a graduate of the University of Florida receiving a B.S. degree in chemistry and mathematics, and has also received an MS degree in pharmacology, and an MBA degree in Marketing/Computer Information Sciences, from the same institution.
2022-04-29 Mr. Strattan is a graduate of the University of Florida receiving a B.S. degree in chemistry and mathematics, and has also received an MS degree in pharmacology, and an MBA degree in Marketing/Computer Information Sciences, from the same institution.
2023-01-31 C.E. Rick Strattan
2023-06-13 Mr. Strattan is a graduate of the University of Florida receiving a B.S. degree in chemistry and mathematics, and has also received an MS degree in pharmacology, and an MBA degree in Marketing/Computer Information Sciences, from the same institution.

Data sourced from SEC filings. Last updated: 2025-10-11